Cargando…
Short-Term Outcomes of Secondary Liver Surgery for Initially Unresectable Colorectal Liver Metastases Following Modern Induction Systemic Therapy in the Dutch CAIRO5 Trial
OBJECTIVE: To present short-term outcomes of liver surgery in patients with initially unresectable colorectal liver metastases (CRLM) downsized by chemotherapy plus targeted agents. BACKGROUND: The increase of complex hepatic resections of CRLM, technical innovations pushing boundaries of respectabi...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10455233/ https://www.ncbi.nlm.nih.gov/pubmed/37635815 http://dx.doi.org/10.1097/AS9.0000000000000081 |
_version_ | 1785096403412844544 |
---|---|
author | Bolhuis, Karen Grosheide, Lodi Wesdorp, Nina J. Komurcu, Aysun Chapelle, Thiery Dejong, Cornelis H. C. Gerhards, Michael F. Grünhagen, Dirk J. van Gulik, Thomas M. Huiskens, Joost De Jong, Koert P. Kazemier, Geert Klaase, Joost M. Liem, Mike S. L. Molenaar, I. Quintus Patijn, Gijs A. Rijken, Arjen M. Ruers, Theo M. Verhoef, Cornelis de Wilt, Johannes H. W. Punt, Cornelis J. A. Swijnenburg, Rutger-Jan |
author_facet | Bolhuis, Karen Grosheide, Lodi Wesdorp, Nina J. Komurcu, Aysun Chapelle, Thiery Dejong, Cornelis H. C. Gerhards, Michael F. Grünhagen, Dirk J. van Gulik, Thomas M. Huiskens, Joost De Jong, Koert P. Kazemier, Geert Klaase, Joost M. Liem, Mike S. L. Molenaar, I. Quintus Patijn, Gijs A. Rijken, Arjen M. Ruers, Theo M. Verhoef, Cornelis de Wilt, Johannes H. W. Punt, Cornelis J. A. Swijnenburg, Rutger-Jan |
author_sort | Bolhuis, Karen |
collection | PubMed |
description | OBJECTIVE: To present short-term outcomes of liver surgery in patients with initially unresectable colorectal liver metastases (CRLM) downsized by chemotherapy plus targeted agents. BACKGROUND: The increase of complex hepatic resections of CRLM, technical innovations pushing boundaries of respectability, and use of intensified induction systemic regimens warrant for safety data in a homogeneous multicenter prospective cohort. METHODS: Patients with initially unresectable CRLM, who underwent complete resection after induction systemic regimens with doublet or triplet chemotherapy, both plus targeted therapy, were selected from the ongoing phase III CAIRO5 study (NCT02162563). Short-term outcomes and risk factors for severe postoperative morbidity (Clavien Dindo grade ≥ 3) were analyzed using logistic regression analysis. RESULTS: A total of 173 patients underwent resection of CRLM after induction systemic therapy. The median number of metastases was 9 and 161 (93%) patients had bilobar disease. Thirty-six (20.8%) 2-stage resections and 88 (51%) major resections (>3 liver segments) were performed. Severe postoperative morbidity and 90-day mortality was 15.6% and 2.9%, respectively. After multivariable analysis, blood transfusion (odds ratio [OR] 2.9 [95% confidence interval (CI) 1.1–6.4], P = 0.03), major resection (OR 2.9 [95% CI 1.1–7.5], P = 0.03), and triplet chemotherapy (OR 2.6 [95% CI 1.1–7.5], P = 0.03) were independently correlated with severe postoperative complications. No association was found between number of cycles of systemic therapy and severe complications (r = −0.038, P = 0.31). CONCLUSION: In patients with initially unresectable CRLM undergoing modern induction systemic therapy and extensive liver surgery, severe postoperative morbidity and 90-day mortality were 15.6% and 2.7%, respectively. Triplet chemotherapy, blood transfusion, and major resections were associated with severe postoperative morbidity. |
format | Online Article Text |
id | pubmed-10455233 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Wolters Kluwer Health, Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-104552332023-08-26 Short-Term Outcomes of Secondary Liver Surgery for Initially Unresectable Colorectal Liver Metastases Following Modern Induction Systemic Therapy in the Dutch CAIRO5 Trial Bolhuis, Karen Grosheide, Lodi Wesdorp, Nina J. Komurcu, Aysun Chapelle, Thiery Dejong, Cornelis H. C. Gerhards, Michael F. Grünhagen, Dirk J. van Gulik, Thomas M. Huiskens, Joost De Jong, Koert P. Kazemier, Geert Klaase, Joost M. Liem, Mike S. L. Molenaar, I. Quintus Patijn, Gijs A. Rijken, Arjen M. Ruers, Theo M. Verhoef, Cornelis de Wilt, Johannes H. W. Punt, Cornelis J. A. Swijnenburg, Rutger-Jan Ann Surg Open Original Study OBJECTIVE: To present short-term outcomes of liver surgery in patients with initially unresectable colorectal liver metastases (CRLM) downsized by chemotherapy plus targeted agents. BACKGROUND: The increase of complex hepatic resections of CRLM, technical innovations pushing boundaries of respectability, and use of intensified induction systemic regimens warrant for safety data in a homogeneous multicenter prospective cohort. METHODS: Patients with initially unresectable CRLM, who underwent complete resection after induction systemic regimens with doublet or triplet chemotherapy, both plus targeted therapy, were selected from the ongoing phase III CAIRO5 study (NCT02162563). Short-term outcomes and risk factors for severe postoperative morbidity (Clavien Dindo grade ≥ 3) were analyzed using logistic regression analysis. RESULTS: A total of 173 patients underwent resection of CRLM after induction systemic therapy. The median number of metastases was 9 and 161 (93%) patients had bilobar disease. Thirty-six (20.8%) 2-stage resections and 88 (51%) major resections (>3 liver segments) were performed. Severe postoperative morbidity and 90-day mortality was 15.6% and 2.9%, respectively. After multivariable analysis, blood transfusion (odds ratio [OR] 2.9 [95% confidence interval (CI) 1.1–6.4], P = 0.03), major resection (OR 2.9 [95% CI 1.1–7.5], P = 0.03), and triplet chemotherapy (OR 2.6 [95% CI 1.1–7.5], P = 0.03) were independently correlated with severe postoperative complications. No association was found between number of cycles of systemic therapy and severe complications (r = −0.038, P = 0.31). CONCLUSION: In patients with initially unresectable CRLM undergoing modern induction systemic therapy and extensive liver surgery, severe postoperative morbidity and 90-day mortality were 15.6% and 2.7%, respectively. Triplet chemotherapy, blood transfusion, and major resections were associated with severe postoperative morbidity. Wolters Kluwer Health, Inc. 2021-07-23 /pmc/articles/PMC10455233/ /pubmed/37635815 http://dx.doi.org/10.1097/AS9.0000000000000081 Text en Copyright © 2021 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. |
spellingShingle | Original Study Bolhuis, Karen Grosheide, Lodi Wesdorp, Nina J. Komurcu, Aysun Chapelle, Thiery Dejong, Cornelis H. C. Gerhards, Michael F. Grünhagen, Dirk J. van Gulik, Thomas M. Huiskens, Joost De Jong, Koert P. Kazemier, Geert Klaase, Joost M. Liem, Mike S. L. Molenaar, I. Quintus Patijn, Gijs A. Rijken, Arjen M. Ruers, Theo M. Verhoef, Cornelis de Wilt, Johannes H. W. Punt, Cornelis J. A. Swijnenburg, Rutger-Jan Short-Term Outcomes of Secondary Liver Surgery for Initially Unresectable Colorectal Liver Metastases Following Modern Induction Systemic Therapy in the Dutch CAIRO5 Trial |
title | Short-Term Outcomes of Secondary Liver Surgery for Initially Unresectable Colorectal Liver Metastases Following Modern Induction Systemic Therapy in the Dutch CAIRO5 Trial |
title_full | Short-Term Outcomes of Secondary Liver Surgery for Initially Unresectable Colorectal Liver Metastases Following Modern Induction Systemic Therapy in the Dutch CAIRO5 Trial |
title_fullStr | Short-Term Outcomes of Secondary Liver Surgery for Initially Unresectable Colorectal Liver Metastases Following Modern Induction Systemic Therapy in the Dutch CAIRO5 Trial |
title_full_unstemmed | Short-Term Outcomes of Secondary Liver Surgery for Initially Unresectable Colorectal Liver Metastases Following Modern Induction Systemic Therapy in the Dutch CAIRO5 Trial |
title_short | Short-Term Outcomes of Secondary Liver Surgery for Initially Unresectable Colorectal Liver Metastases Following Modern Induction Systemic Therapy in the Dutch CAIRO5 Trial |
title_sort | short-term outcomes of secondary liver surgery for initially unresectable colorectal liver metastases following modern induction systemic therapy in the dutch cairo5 trial |
topic | Original Study |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10455233/ https://www.ncbi.nlm.nih.gov/pubmed/37635815 http://dx.doi.org/10.1097/AS9.0000000000000081 |
work_keys_str_mv | AT bolhuiskaren shorttermoutcomesofsecondaryliversurgeryforinitiallyunresectablecolorectallivermetastasesfollowingmoderninductionsystemictherapyinthedutchcairo5trial AT grosheidelodi shorttermoutcomesofsecondaryliversurgeryforinitiallyunresectablecolorectallivermetastasesfollowingmoderninductionsystemictherapyinthedutchcairo5trial AT wesdorpninaj shorttermoutcomesofsecondaryliversurgeryforinitiallyunresectablecolorectallivermetastasesfollowingmoderninductionsystemictherapyinthedutchcairo5trial AT komurcuaysun shorttermoutcomesofsecondaryliversurgeryforinitiallyunresectablecolorectallivermetastasesfollowingmoderninductionsystemictherapyinthedutchcairo5trial AT chapellethiery shorttermoutcomesofsecondaryliversurgeryforinitiallyunresectablecolorectallivermetastasesfollowingmoderninductionsystemictherapyinthedutchcairo5trial AT dejongcornelishc shorttermoutcomesofsecondaryliversurgeryforinitiallyunresectablecolorectallivermetastasesfollowingmoderninductionsystemictherapyinthedutchcairo5trial AT gerhardsmichaelf shorttermoutcomesofsecondaryliversurgeryforinitiallyunresectablecolorectallivermetastasesfollowingmoderninductionsystemictherapyinthedutchcairo5trial AT grunhagendirkj shorttermoutcomesofsecondaryliversurgeryforinitiallyunresectablecolorectallivermetastasesfollowingmoderninductionsystemictherapyinthedutchcairo5trial AT vangulikthomasm shorttermoutcomesofsecondaryliversurgeryforinitiallyunresectablecolorectallivermetastasesfollowingmoderninductionsystemictherapyinthedutchcairo5trial AT huiskensjoost shorttermoutcomesofsecondaryliversurgeryforinitiallyunresectablecolorectallivermetastasesfollowingmoderninductionsystemictherapyinthedutchcairo5trial AT dejongkoertp shorttermoutcomesofsecondaryliversurgeryforinitiallyunresectablecolorectallivermetastasesfollowingmoderninductionsystemictherapyinthedutchcairo5trial AT kazemiergeert shorttermoutcomesofsecondaryliversurgeryforinitiallyunresectablecolorectallivermetastasesfollowingmoderninductionsystemictherapyinthedutchcairo5trial AT klaasejoostm shorttermoutcomesofsecondaryliversurgeryforinitiallyunresectablecolorectallivermetastasesfollowingmoderninductionsystemictherapyinthedutchcairo5trial AT liemmikesl shorttermoutcomesofsecondaryliversurgeryforinitiallyunresectablecolorectallivermetastasesfollowingmoderninductionsystemictherapyinthedutchcairo5trial AT molenaariquintus shorttermoutcomesofsecondaryliversurgeryforinitiallyunresectablecolorectallivermetastasesfollowingmoderninductionsystemictherapyinthedutchcairo5trial AT patijngijsa shorttermoutcomesofsecondaryliversurgeryforinitiallyunresectablecolorectallivermetastasesfollowingmoderninductionsystemictherapyinthedutchcairo5trial AT rijkenarjenm shorttermoutcomesofsecondaryliversurgeryforinitiallyunresectablecolorectallivermetastasesfollowingmoderninductionsystemictherapyinthedutchcairo5trial AT ruerstheom shorttermoutcomesofsecondaryliversurgeryforinitiallyunresectablecolorectallivermetastasesfollowingmoderninductionsystemictherapyinthedutchcairo5trial AT verhoefcornelis shorttermoutcomesofsecondaryliversurgeryforinitiallyunresectablecolorectallivermetastasesfollowingmoderninductionsystemictherapyinthedutchcairo5trial AT dewiltjohanneshw shorttermoutcomesofsecondaryliversurgeryforinitiallyunresectablecolorectallivermetastasesfollowingmoderninductionsystemictherapyinthedutchcairo5trial AT puntcornelisja shorttermoutcomesofsecondaryliversurgeryforinitiallyunresectablecolorectallivermetastasesfollowingmoderninductionsystemictherapyinthedutchcairo5trial AT swijnenburgrutgerjan shorttermoutcomesofsecondaryliversurgeryforinitiallyunresectablecolorectallivermetastasesfollowingmoderninductionsystemictherapyinthedutchcairo5trial |